文献速递关节外科

清创、抗生素及假体保留联合模块组件更换治疗急性培养阴性假体周围关节感染的结果

Outcome of Debridement, Antibiotics, and Implant Retention With Modular Component Exchange in Acute Culture-Negative Periprosthetic Joint Infections.
PubMed 文献 · J Arthroplasty · 2020-09-07

本研究评估了149例初次全关节置换后急性假体周围关节感染(PJI)患者接受清创、抗生素及假体保留(DAIR)联合模块组件更换的结局,其中培养阴性46例、培养阳性103例。培养阴性组再感染率为13.0%,培养阳性组为19.4%(P=0.48),两组无显著差异;无菌翻修率分别为8.7%和4.9%(P=0.46)。作者认为培养阴性可能不是急性PJI行DAIR的禁忌证。

要点

  • 急性培养阴性PJI行DAIR联合模块组件更换的再感染率为13.0%,培养阳性组为19.4%(P=0.48)。
  • 培养阴性组与培养阳性组再感染平均生存时间分别为7.7±0.4年和7.4±0.3年(P=0.40)。
  • 无菌翻修率培养阴性组8.7%、培养阳性组4.9%(P=0.46),两组植入物失败主因均为松动。

核心结论

  • 尽管缺乏可指导术后抗生素治疗的病原体,急性培养阴性PJI行DAIR联合模块组件更换的再感染率与急性培养阳性PJI相似,提示培养阴性可能不是急性PJI患者行DAIR的禁忌证。

研究设计与样本

  • 共纳入149例因急性PJI接受DAIR联合模块组件更换的初次全关节置换患者,包括90例全膝关节置换和59例全髋关节置换,随访至少3年。

主要发现

  • 培养阴性PJI组46例,培养阳性PJI组103例。
  • 培养阴性组再感染率为13.0%,培养阳性组为19.4%(P=0.48)。
  • 培养阴性组再感染平均生存时间为7.7±0.4年,培养阳性组为7.4±0.3年(P=0.40),两组无显著差异。
  • 无菌翻修率培养阴性组为8.7%,培养阳性组为4.9%(P=0.46)。
  • 两组植入物失败的主要原因均为松动。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Modular component exchange and culture-directed antibiotic treatment is routinely employed for acute periprosthetic joint infection (PJI). However, as many as 7%-23% of PJIs have been reported to yield negative culture results. The efficacy of debridement, antibiotics, and implant retention (DAIR) with modular component exchange in the setting of acute culture negative PJI remains largely unknown. The aim of our study is to evaluate the outcomes of DAIR with modular component exchange in acute culture-positive and culture-negative PJI. METHODS: A total of 149 consecutive patients with primary total joint replacements (90 total knee arthroplasties and 59 total hip arthroplasties) who underwent DAIR with modular component exchange for acute PJI with at least 3 years of follow-up were evaluated: (1) 46 culture-negative PJI patients and (2) 103 culture-positive PJI patients. Reinfection and aseptic revision rates along with complication rates were compared. RESULTS: The reinfection rate for DAIR in acute culture-negative PJI was 13.0% compared to 19.4% in culture-positive PJI (P = .48). Mean survival time from reinfection between culture-negative (7.7 ± 0.4 years) and culture-positive (7.4 ± 0.3 years) PJI groups did not differ significantly (P = .40). Aseptic revision rates were 8.7% and 4.9% (P = .46), respectively, with loosening being the primary reason for implant failure in both cohorts. CONCLUSIONS: Despite lack of an identifying organism to guide postoperative antibiotic therapy, DAIR with modular component exchange for acute culture-negative PJI was associated with similar reinfection rates compared to acute culture-positive PJI, suggesting that culture negativity may not be a contraindication to DAIR in patients with acute PJI.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Tirumala V, Smith E, Box H, et al. Outcome of Debridement, Antibiotics, and Implant Retention With Modular Component Exchange in Acute Culture-Negative Periprosthetic Joint Infections. J Arthroplasty. 2020. PMID: 32981773. doi:10.1016/j.arth.2020.08.065

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。